Treatment of patients with metastatic colorectal cancer and poor performance status: current evidence and challenges

Patients with unresectable metastatic colorectal cancer live for a median of three years when treated with standard therapies. While the evidence guiding cancer-directed treatment of this disease comes from phase III trials that have mostly enrolled patients with good performance status, some patien...

Descripción completa

Detalles Bibliográficos
Autores principales: Rocha, Lucila Soares da Silva, Riechelmann, Rachel P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo 2018
Materias:
Review Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142860/
https://www.ncbi.nlm.nih.gov/pubmed/30281700
http://dx.doi.org/10.6061/clinics/2018/e542s

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6142860/
https://www.ncbi.nlm.nih.gov/pubmed/30281700
http://dx.doi.org/10.6061/clinics/2018/e542s

Ejemplares similares